ACADIA PHARMACEUTICALS INC
ACAD
17 insider filings · Latest: Jul 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Jul 31 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Sale | 16,558 | $26.13 | $432.7K | 18,994(D) | View → |
| May 26, 2026 | May 27 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 5,401 | $21.18 | $114.4K | 24,509(D) | View → |
| May 4, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Sale | 1,332 | $21.79 | $29.0K | 29,129(D) | View → |
| May 4, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Sale | 3,506 | $21.79 | $76.4K | 66,145(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Mar 10 10:00 PM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Grant/Award | 131,122 | $22.16 | 29,548(D) | View → |
| Mar 6, 2026 | Mar 10 10:00 PM | Adams Catherine OwenDirector, Chief Executive Officer | Grant/Award | 339,514 | $22.16 | 76,509(D) | View → |
← Previous
Page 2 of 2